Vivek Upadhyay, Vikas Trivedi, Gaurang Shah, Manish Yadav, Pranav S. Shrivastav. Determination of mycophenolic acid in human plasma by ultra performance liquid chromatography tandem mass spectrometry[J]. Journal of Pharmaceutical Analysis, 2014, (3): 205-216. doi: 10.1016/j.jpha.2013.06.001
Citation:
Vivek Upadhyay, Vikas Trivedi, Gaurang Shah, Manish Yadav, Pranav S. Shrivastav. Determination of mycophenolic acid in human plasma by ultra performance liquid chromatography tandem mass spectrometry[J]. Journal of Pharmaceutical Analysis, 2014, (3): 205-216. doi: 10.1016/j.jpha.2013.06.001
Vivek Upadhyay, Vikas Trivedi, Gaurang Shah, Manish Yadav, Pranav S. Shrivastav. Determination of mycophenolic acid in human plasma by ultra performance liquid chromatography tandem mass spectrometry[J]. Journal of Pharmaceutical Analysis, 2014, (3): 205-216. doi: 10.1016/j.jpha.2013.06.001
Citation:
Vivek Upadhyay, Vikas Trivedi, Gaurang Shah, Manish Yadav, Pranav S. Shrivastav. Determination of mycophenolic acid in human plasma by ultra performance liquid chromatography tandem mass spectrometry[J]. Journal of Pharmaceutical Analysis, 2014, (3): 205-216. doi: 10.1016/j.jpha.2013.06.001
A simple, sensitive and high throughput ultra performance liquid chromatography tandem mass spectrometry method has been developed for the determination of mycophenolic acid in human plasma. The method involved simple protein precipitation of MPA along with its deuterated analog as an internal standard (IS) from 50 mL of human plasma. The chromatographic analysis was done on Acquity UPLC C18 (100mm*2.1mm,1.7mm) column under isocratic conditions using acetonitrile and 10 mM ammonium formate, pH 3.00 (75:25, v/v) as the mobile phase. A triple quadrupole mass spectrometer operating in the positive ionization mode was used for quantitation. In-source conversion of mycophenolic glucuronide metabolite to the parent drug was selectively controlled by suitable optimization of cone voltage, cone gas flow and desolvation temperature. The method was validated over a wide concentration range of 15–15000 ng/mL. The mean extraction recovery for the analyte and IS was 495%. Matrix effect expressed as matrix factors ranged from 0.97 to 1.02. The method was successfully applied to support a bioequivalence study of 500 mg mycophenolate mofetil tablet in 72 healthy subjects.